Home　>　News from Portfolio Companies　>　November 2008

November 2008

CBP501 Enters Phase II Trials for the Treatment of Malignant Pleural Mesothelioma

November 10, 2008

CanBas Co., Ltd. (Numazu, Shizuoka, "CanBas") and Takeda Pharmaceutical Company Limited (Osaka, "Takeda") togeth...

more

top

Contact Us

Business Guide

  • Our Services
  • Important Theme
  • Focused Sector

Keyword

About Us

  • Hokkaido Venture Capital, Inc.
  • HVC Strategic ResearchInstitute, Inc.
  • Access

Tokyo Tatemono Sapporo Bldg. 2nd Fl., 20 North 7, West 2, Kita-ku, Sapporo, Hokkaido 060-0807 Japan